Elevated PAI-1 expression in many cancers, such as glioma, ovarian cancer, and pancreatic cancer, was associated with unfavorable patient outcomes 42, 43, suggesting its potential role in tumor promotion. This evidence concerns the gene SERPINE1 and neoplasm.